drugset
drugset / Trial / NCT06066060

A DDI Study of JMKX000623 and Metformin Hydrochloride

NCT06066060 ↗

Phase 1 Completed 24 enrolled Jemincare
NaSingle-groupOpen-labelOther

Summary

A phase 1, single center, 1 sequence, 3 period, open label, multiple doses study to evaluate the drug-drug interaction of JMKX000623 tablet and metformin.

Timeline

Start
2023-09-17
Primary completion
2023-11-06
Completion
2023-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject JMKX000623 Unknown — Oral
Subject Metformin Small molecule — Oral

Indications

No indication recorded.